JAK Inhibitors

Author(s)/Faculty: Gary R. Lichtenstein, MD
Release Date: 8/22/2016Expiration Date: 8/21/2018
Credit Type: CMENumber of Credits: 0.25
Content Type: VideoProvider: Vindico Medical Education
Janus kinase (JAK) inhibitors have emerged as  novel, orally administered small molecule therapies for the treatment of inflammatory bowel disease. In this CME activity, Dr. Gary Lichtenstein discusses the data on these investigational agents, with an emphasis on information presented at Digestive Disease Week 2016.